Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

CUSIP: 15117F807

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 5 signals
Share change
+120,497
SEC-reported price per share
$2.14
Number of holders
1
Value change
+$257,864
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
43,754,363

Security key

15117F807

Report period

Q3 2025

Institutions

1

Top holders

0

Ownership snapshot

Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
Orin Hirschman
Comparable rows
15/15
Latest evidence
01 Jul 2025
13D/G 13F Lead comparable stake: 5% 13D/G row: INTRACOASTAL CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
INTRACOASTAL CAPITAL, LLC 5%
Orin Hirschman 4.9%
Laurence W. Lytton 1.6%
ADAR1 Capital Management, LLC 0.1%
Nantahala Capital Management, LLC 0.06%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
140,101 shares
$0 01 Jul 2025
Orin Hirschman
13D/G
4.9%
$586,444
2,022,221 shares
$0 31 Dec 2024
Laurence W. Lytton
13D/G
LYTTON LAURENCE W
1.6%
$250,788
51,391 shares
$0 30 Jun 2025
ADAR1 Capital Management, LLC
13D/G
0.1%
2,962 shares
$0 30 Jun 2025
Nantahala Capital Management, LLC
13D/G
0.06%
$5,412
1,109 shares
$0 30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
0.65%
$400,585
56,341 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of CLRB - Cellectar Biosciences, Inc. - Common stock, par value $0.00001 as of Q3 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .